AlphaCentric Advisors’s Viridian Therapeutics VRDN Stock Holding History

AlphaCentric Advisors’s Portfolio VRDN Stock Details VRDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell
2024 Q3	$341K	Buy
2024 Q2	$163K	Buy
2024 Q1	$105K	Buy
2023 Q4	–	Sell
2023 Q3	$1.23M	Buy
2023 Q2	$845K	Hold
2023 Q1	$903K	Hold
2022 Q4	$1.04M	Hold
2022 Q3	$728K	Buy